jobs.jnj.com/en/jobs/

✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Share

Global Public Health
News & Press Releases

Media Statement

November 15, 2022

Johnson & Johnson Rises to #2 in Ranking of Companies’ Efforts to Expand Access to Medicines Worldwide
Global Public Health

June 20, 2022

Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research
Global Public Health

May 23, 2022

New Global Surgery Initiative Aims to Improve Access to Quality Surgical Care in Resource-Limited Settings
MEDIA STATEMENT

January 27, 2022

Johnson & Johnson Marks More Than 2 Billion Doses of Medicine Donated to Date to Help Combat Intestinal Worms
Global Public Health

November 18, 2021

Johnson & Johnson is Proud to Lead Efforts to Outpace Antimicrobial Resistance
Innovation

The Sky's the Limit: Drones Delivering HIV Supplies in Remote Uganda
Innovation

July 22, 2021

How Drones Are Being Used to Deliver Lifesaving HIV Drugs to Remote Areas of the World
Personal Stories

July 19, 2021

"1.5 Million Children Are Living With HIV in Sub-Saharan Africa. I'm One of the Doctors Treating These Young Patients Every Day"
Innovation

How the New Horizons Collaborative is Transforming Pediatric HIV in Uganda
Our Company

July 09, 2021

Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats
Innovation

October 01, 2020

Q&A: The need for flexibility and innovation in TB care — now more than ever
Latest News

September 30, 2020

Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19
Our Company

September 23, 2020

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
Our Company

July 30, 2020

Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Innovation

June 17, 2020

Opinion: Why global health security is every company's business
Latest News

July 07, 2020

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study
Our Company

June 10, 2020

Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July
Our Company

April 24, 2020

Statement of Support on Access to New COVID-19 Tools
Our Company

March 30, 2020

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Our Company

October 08, 2020

How Rwanda is Spearheading Efforts to Tackle Mental Health
Innovation

July 06, 2020

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO^® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries
Innovation

July 01, 2020

Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine
Innovation

May 27, 2020

U.S. FDA Approves New Pediatric Formulation of SIRTURO^® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
Innovation

May 27, 2020

Drug-Resistant Tuberculosis Lifeline QuickFire Challenge
Innovation

April 23, 2020

Global Advocacy and Communications Effort Launched to Drive Action Against COVID-19 and Stop Future Pandemics
Our Company

March 24, 2020

Statement on the Occasion of World Tuberculosis Day
Innovation

March 20, 2020

Janssen Announces Health Canada Approval of CABENUVA™, the First Long-Acting Regimen for the Treatment of HIV
Innovation

March 11, 2020

Janssen Announces Results of Phase 3 Study Demonstrating the Safety and Efficacy of Long-Acting Injectable HIV Treatment Regimen of Rilpivirine And Cabotegravir through 96 Weeks
Innovation

February 18, 2020

Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments
Innovation

February 11, 2020

Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine
Our Company

January 29, 2020

Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
Our Company

January 23, 2020

Johnson & Johnson Recognized as Industry Leader in New AMR Benchmark
Innovation

January 16, 2020

Johnson & Johnson Collaborates with The MTV Staying Alive Foundation to Launch Youth-Focused “Edutainment” Campaign Focused on Tuberculosis & Other Health Issues in India
Innovation

December 16, 2019

World Health Organization Recommends the Use of Bedaquiline-Containing Treatment Regimens For All Drug-Resistant Tuberculosis Patients
Our Company

December 08, 2019

Johnson & Johnson Announces Commitment to Support Republic of Rwanda’s Preparedness Against Ebola Outbreak
Innovation

November 07, 2019

Johnson & Johnson Announces Submission of European Marketing Authorisation Applications for Janssen’s Investigational Ebola Vaccine Regimen
Innovation

October 31, 2019

Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen’s Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
Global Public Health

October 30, 2019

Johnson & Johnson Expands Efforts to Help End Tuberculosis in India
Our Company

October 04, 2019

Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
Innovation

September 04, 2019

Johnson & Johnson Expands First-of-its-Kind Pediatric HIV Program to Zimbabwe
Innovation

August 22, 2019

Janssen Reports Positive Top-line Phase 3 Study Results of Investigational, Long-acting Injectable HIV Treatment Regimen Administered Every Two Months
Innovation

July 16, 2019

Johnson & Johnson Extends Long-Standing Donation Program to Support Global Effort to Tackle Intestinal Worms
Innovation

April 29, 2019

Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV
Innovation

September 24, 2018

Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis, the World’s #1 Infectious Killer
Innovation

August 07, 2018

Johnson & Johnson Announces Series of Collaborations Aimed at Transforming Mental Health Care in Low-Resource Settings